Showing results (361-370 of 541) with videos related to

Sort By:
Pageof 55
Drugs - Real World Outcomes|January 17, 2025
Effectiveness and Safety of Vildagliptin Sustained Release in the Management of Type 2 Diabetes Mellitus: Real-World Evidence in Indian Patients [NOVELTY Study]Rakesh Sahay, Anil Bhansali, Surendra Kumar Sharma, et al.
Drugs - Real World Outcomes|October 9, 2024
Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE StudyBruno Fautrel, Yoram Bouhnik, Carine Salliot, et al.
Drugs - Real World Outcomes|September 8, 2024
Real World Evidence of User Experience with Microenemas for Relief of ConstipationStefanie Rasche, Christer Spegel, Katarina Lundh
Drugs - Real World Outcomes|August 10, 2024
Real-World Amount of Clotting Factor Products and Non-Factor Products Dispensed and Annual Medical Expenditures for Japanese Patients with Haemophilia AMasato Bingo, Katsuyuki Fukutake, Kanae Togo, et al.
Drugs - Real World Outcomes|August 8, 2024
Prescribing Cascades of Loop Diuretics and Anti-vertigo Drugs Following Treatment with Gabapentinoids and Benzodiazepines: Prescription Sequence Symmetry Analysis of a Large-Scale Claims Database Including Japanese Older AdultsRina Omata, Akane Asami, Azusa Hara, et al.
Drugs - Real World Outcomes|July 20, 2024
The Association Between Deep Vein Thrombosis, Pulmonary Embolism, and Janus Kinase Inhibitors: Reporting Status and Signal Detection in the Japanese Adverse Drug Event Report DatabaseTae Maeshima, Sayaka Aisu, Naoki Ohkura, et al.
Drugs - Real World Outcomes|June 19, 2024
Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations Previously Treated with Platinum-Based Chemotherapy and ImmunotherapyJerome H Goldschmidt, Wan-Yu Tseng, Yunfei Wang, et al.
Drugs - Real World Outcomes|June 24, 2024
Falls and Fractures among Nursing Home Residents Treated with Pimavanserin versus Other Atypical Antipsychotics: Analysis of Medicare Beneficiaries with Parkinson's Disease PsychosisKrithika Rajagopalan, Nazia Rashid, Daksha Gopal, et al.
Drugs - Real World Outcomes|June 14, 2024
Incidence of Liver and Non-liver Cancers After Hepatitis C Virus Eradication: A Population-Based Cohort StudyJosé Ríos, Víctor Sapena, Zoe Mariño, et al.
Drugs - Real World Outcomes|January 23, 2026
Safety and Effectiveness of a Fixed-Dose Combination of Cephalexin Extended Release and Clavulanate Potassium in Bacterial Sore Throat and Uncomplicated Skin and Soft-Tissue Infections: A Multicentre, Open-Label, Phase IV Study in IndiaSunil Panda, Shrinivas Chavan, Sumit Agarwal, et al.
Pageof 55